Oncolytics Biotech Inc. announced that Brad Thompson Ph.D. has stepped down as President and Chief Executive Officer of the company effective immediately. The company's Chief Operating Officer, Matt Coffey, has been appointed as Interim President and Chief Executive Officer while the company conducts a search for Dr. Thompson's replacement.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.59 CAD | -5.92% | -0.62% | -11.17% |
May. 09 | Oncolytics Biotech Reports a First-Quarter Loss of Near $7 Million | MT |
May. 09 | Transcript : Oncolytics Biotech Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.17% | 87.77M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- ONC Stock
- News Oncolytics Biotech Inc.
- Oncolytics Biotech Inc. Announces Management Changes